{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:59:49Z","timestamp":1790909989764,"version":"4.1.0"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T00:00:00Z","timestamp":1678233600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:p>\n                    Coronary artery bypass grafting (CABG) is the most frequently performed cardiac surgery worldwide. The reported incidence of graft failure ranges between 10% and 50%, depending upon the type of conduit used. Thrombosis is the predominant mechanism of early graft failure, occurring in both arterial and vein grafts. Significant advances have been made in the field of antithrombotic therapy since the introduction of aspirin, which is regarded as the cornerstone of antithrombotic therapy for prevention of graft thrombosis. Convincing evidence now exists that dual antiplatelet therapy (DAPT), consisting of aspirin and a potent oral P2Y\n                    <jats:sub>12<\/jats:sub>\n                    inhibitor, effectively reduces the incidence of graft failure. However, this is achieved at the expense of an increase in clinically important bleeding, underscoring the importance of balancing thrombotic risk and bleeding risk when considering antithrombotic therapy after CABG. In contrast, anticoagulant therapy has proved ineffective at reducing the occurrence of graft thrombosis, pointing to platelet aggregation as the key driver of graft thrombosis. We provide a comprehensive review of current practice for prevention of graft thrombosis and discuss potential future concepts for antithrombotic therapy including P2Y\n                    <jats:sub>12<\/jats:sub>\n                    inhibitor monotherapy and short-term DAPT.\n                  <\/jats:p>","DOI":"10.3389\/fcvm.2023.1125126","type":"journal-article","created":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T01:36:00Z","timestamp":1678239360000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":37,"title":["Graft thrombosis after coronary artery bypass surgery and current practice for prevention"],"prefix":"10.3389","volume":"10","author":[{"given":"Lamia","family":"Harik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Perezgrovas-Olaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Giovanni","family":"Soletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaldo","family":"Dimagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talal","family":"Alzghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin R.","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Cancelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Gaudino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigrid","family":"Sandner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,3,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.athoracsur.2021.03.043","article-title":"STS Adult cardiac surgery database: 2021 update on outcomes, quality, and research","volume":"111","author":"Bowdish","year":"","journal-title":"Ann Thorac Surg"},{"key":"B2","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.1016\/j.jacc.2004.08.064","article-title":"Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery","volume":"44","author":"Goldman","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1161\/CIRCULATIONAHA.119.045427","article-title":"Long-term results of the RAPCO trials","volume":"142","author":"Buxton","year":"2020","journal-title":"Circulation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/0735-1097(96)00206-9","article-title":"Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years","volume":"28","author":"Fitzgibbon","year":"1996","journal-title":"J Am Coll Cardiol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1161\/CIRCULATIONAHA.117.027597","article-title":"Mechanisms, consequences, and prevention of coronary graft failure","volume":"136","author":"Gaudino","year":"2017","journal-title":"Circulation"},{"key":"B6","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/s41569-019-0249-3","article-title":"Saphenous vein grafts in contemporary coronary artery bypass graft surgery","volume":"17","author":"Caliskan","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.athoracsur.2017.10.058","article-title":"Operative outcomes of multiple-arterial versus single-arterial coronary bypass grafting","volume":"105","author":"Schwann","year":"2018","journal-title":"Ann Thorac Surg"},{"key":"B8","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1097\/SLA.0b013e318288c38d","article-title":"Saphenous vein graft failure after coronary artery bypass surgery: pathophysiology, management, and future directions","volume":"257","author":"Harskamp","year":"2013","journal-title":"Ann Surg"},{"key":"B9","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1161\/01.CIR.97.9.916","article-title":"Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention","volume":"97","author":"Motwani","year":"1998","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/eurheartj\/ehab096","article-title":"The association between coronary graft patency and clinical status in patients with coronary artery disease","volume":"42","author":"Gaudino","year":"2021","journal-title":"Eur Heart J"},{"key":"B11","doi-asserted-by":"publisher","first-page":"736503","DOI":"10.3389\/fcvm.2021.736503","article-title":"A novel endothelial damage inhibitor reduces oxidative stress and improves cellular integrity in radial artery grafts for coronary artery bypass","volume":"8","author":"Aschacher","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B12","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/CIRCULATIONAHA.120.052163","article-title":"Saphenous vein graft failure: from pathophysiology to prevention and treatment strategies","volume":"144","author":"Xenogiannis","year":"2021","journal-title":"Circulation"},{"key":"B13","doi-asserted-by":"publisher","first-page":"14179","DOI":"10.1038\/s41598-017-13819-w","article-title":"Limiting injury during saphenous vein graft preparation for coronary arterial bypass prevents metabolic decompensation","volume":"7","author":"Cheung-Flynn","year":"2017","journal-title":"Sci Rep"},{"key":"B14","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1016\/S0008-6363(99)00171-6","article-title":"Nitric oxide and the proliferation of vascular smooth muscle cells","volume":"43","author":"Jeremy","year":"1999","journal-title":"Cardiovasc Res"},{"key":"B15","first-page":"E305","article-title":"A randomized controlled trial of prasugrel for prevention of early saphenous vein graft thrombosis","volume":"32","author":"Danek","year":"2020","journal-title":"J Invasive Cardiol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1016\/S0140-6736(84)92446-2","article-title":"Improved aortocoronary bypass patency by low-dose aspirin (100 mg daily)","volume":"323","author":"Lorenz","year":"1984","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1161\/01.CIR.80.5.1190","article-title":"Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a veterans administration cooperative study","volume":"80","author":"Goldman","year":"1989","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/1010-7940(93)90155-5","article-title":"Optimal antithrombotic therapy following aortocoronary bypass: a meta-analysis","volume":"7","author":"Fremes","year":"1993","journal-title":"Eur J Cardiothorac Surg"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1136\/bmj.327.7427.1309","article-title":"Indirect comparison meta-analysis of aspirin therapy after coronary surgery","volume":"327","author":"Lim","year":"2003","journal-title":"Br Med J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/jth.12832","article-title":"Multiple daily doses of acetyl-salicylic acid (ASA) overcome reduced platelet response to once-daily ASA after coronary artery bypass graft surgery: a pilot randomized controlled trial","volume":"13","author":"Paikin","year":"2015","journal-title":"J Thromb Haemost"},{"key":"B21","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/cpt.702","article-title":"On-pump cardiac surgery enhances platelet renewal and impairs aspirin pharmacodynamics: effects of improved dosing regimens: aspirin pharmacodynamics after cardiac surgery","volume":"102","author":"Cavalca","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"B22","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1161\/01.CIR.0000081770.51929.5A","article-title":"Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery","volume":"108","author":"Zimmermann","year":"2003","journal-title":"Circulation"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000001039","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: executive summary: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"B24","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur Heart J"},{"key":"B25","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1016\/B978-0-12-386456-7.06207-9","article-title":"The platelet as a target for damage","volume-title":"Pathobiology of human disease","author":"Tran","year":"2014"},{"key":"B26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1038\/nrcardio.2014.156","article-title":"Novel antiplatelet agents in acute coronary syndrome","volume":"12","author":"Franchi","year":"2015","journal-title":"Nat Rev Cardiol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.jcin.2019.03.034","article-title":"Updated expert consensus statement on platelet function and genetic testing for guiding P2Y12 receptor inhibitor treatment in percutaneous coronary intervention","volume":"12","author":"Sibbing","year":"2019","journal-title":"JACC Cardiovasc Interv"},{"key":"B28","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jcin.2020.01.226","article-title":"Derivation, validation, and prognostic utility of a prediction rule for nonresponse to clopidogrel","volume":"13","author":"Angiolillo","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jacc.2009.10.043","article-title":"Impact of chronic kidney disease on platelet function profiles in diabetes mellitus patients with coronary artery disease taking dual antiplatelet therapy","volume":"55","author":"Angiolillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1080\/14779072.2020.1792293","article-title":"An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitus","volume":"18","author":"Calderone","year":"2020","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1161\/CIRCULATIONAHA.120.046786","article-title":"Comparative efficacy and safety of oral P2Y 12 inhibitors in acute coronary syndrome: network meta-analysis of 52 816 patients from 12 randomized trials","volume":"142","author":"Navarese","year":"2020","journal-title":"Circulation"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","article-title":"Ticagrelor versus clopidogrel in patients with acute coronary syndromes","volume":"361","author":"Wallentin","year":"2009","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1007\/s40262-015-0290-2","article-title":"Ticagrelor: pharmacokinetic, pharmacodynamic and pharmacogenetic profile: an update","volume":"54","author":"Teng","year":"2015","journal-title":"Clin Pharmacokinet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.1161\/CIRCULATIONAHA.110.978007","article-title":"Aspirin plus clopidogrel versus aspirin alone after coronary artery bypass grafting: the clopidogrel after surgery for coronary artery disease (CASCADE) trial","volume":"122","author":"Kulik","year":"2010","journal-title":"Circulation"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1136\/heartjnl-2012-302449","article-title":"Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of coronary arteRY bypaSS occlusion after off-pump procedures) randomised study","volume":"98","author":"Mannacio","year":"2012","journal-title":"Heart"},{"key":"B36","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/jocs.12074","article-title":"Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis: dual anti-platelet therapy after coronary artery","volume":"28","author":"Deo","year":"2013","journal-title":"J Card Surg"},{"key":"B37","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1161\/CIR.0000000000000182","article-title":"Secondary prevention after coronary artery bypass graft surgery: a scientific statement from the American heart association","volume":"131","author":"Kulik","year":"2015","journal-title":"Circulation"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.amjcard.2013.07.017","article-title":"Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting","volume":"112","author":"Nocerino","year":"2013","journal-title":"Am J Cardiol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1001\/jama.2018.3197","article-title":"Effect of ticagrelor plus aspirin, ticagrelor alone, or aspirin alone on saphenous vein graft patency 1 year after coronary artery bypass grafting: a randomized clinical trial","volume":"319","author":"Zhao","year":"2018","journal-title":"JAMA"},{"key":"B40","doi-asserted-by":"publisher","first-page":"1799","DOI":"10.1161\/CIRCULATIONAHA.120.050749","article-title":"Effect of adding ticagrelor to standard aspirin on saphenous vein graft patency in patients undergoing coronary artery bypass grafting (POPular CABG): a randomized, double-blind, placebo-controlled trial","volume":"142","author":"Willemsen","year":"2020","journal-title":"Circulation"},{"key":"B41","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ijcard.2018.07.083","article-title":"Dual versus single antiplatelet therapy after coronary artery bypass graft surgery: an updated meta-analysis","volume":"269","author":"Cardoso","year":"2018","journal-title":"Int J Cardiol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"l5476","DOI":"10.1136\/bmj.l5476","article-title":"Antithrombotic treatment after coronary artery bypass graft surgery: systematic review and network meta-analysis","author":"Solo","year":"2019","journal-title":"Br Med J"},{"key":"B43","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1001\/jama.2022.11966","article-title":"Association of dual antiplatelet therapy with ticagrelor with vein graft failure after coronary artery bypass graft surgery: a systematic review and meta-analysis","volume":"328","author":"Sandner","year":"2022","journal-title":"JAMA"},{"key":"B44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1093\/ejcts\/ezx314","article-title":"2017 EACTS guidelines on perioperative medication in adult cardiac surgery","volume":"53","author":"Sousa-Uva","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"B45","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/ejcts\/ezx334","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS","volume":"53","author":"Valgimigli","year":"2018","journal-title":"Eur J Cardiothorac Surg"},{"key":"B46","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.athoracsur.2009.04.024","article-title":"Clopidogrel and aspirin versus clopidogrel alone on graft patency after coronary artery bypass grafting","volume":"88","author":"Gao","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"B47","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/jocs.16189","article-title":"Ticagrelor versus aspirin and vein graft patency after coronary bypass: a randomized trial","volume":"37","author":"Kulik","year":"2022","journal-title":"J Card Surg"},{"key":"B48","doi-asserted-by":"publisher","first-page":"2432","DOI":"10.1093\/eurheartj\/ehz185","article-title":"Randomized trial of ticagrelor vs. Aspirin in patients after coronary artery bypass grafting: the TiCAB trial","volume":"40","author":"Schunkert","year":"2019","journal-title":"Eur Heart J"},{"key":"B49","first-page":"II22","article-title":"Improved graft patency with anticoagulant therapy after aortocoronary bypass surgery: a prospective, randomized study","volume":"64","author":"Gohlke","year":"1981","journal-title":"Circulation"},{"key":"B50","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1056\/NEJM197911013011803","article-title":"Failure of antiplatelet and anticoagulant therapy to improve patency of grafts after coronary-artery bypass: a controlled, randomized study","volume":"301","author":"Pantely","year":"1979","journal-title":"N Engl J Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0022-5223(19)37328-3","article-title":"The effect of antithrombotic therapy on patency rates of saphenous vein coronary artery bypass grafts","volume":"83","author":"McEnany","year":"1982","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jacc.2018.10.048","article-title":"Rivaroxaban, aspirin, or both to prevent early coronary bypass graft occlusion","volume":"73","author":"Lamy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1161\/01.CIR.65.7.90","article-title":"Changes in grafts and coronary arteries after saphenous vein aortocoronary bypass surgery: results at repeat angiography","volume":"65","author":"Bourassa","year":"1982","journal-title":"Circulation"},{"key":"B54","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1093\/oxfordjournals.eurheartj.a061378","article-title":"Angina pectoris, one to 10 years after aorto-coronary bypass surgery","volume":"4","author":"Laird-Meeter","year":"1983","journal-title":"Eur Heart J"},{"key":"B55","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCULATIONAHA.111.040311","article-title":"Relationship between vein graft failure and subsequent clinical outcomes after coronary artery bypass surgery","volume":"125","author":"Lopes","year":"2012","journal-title":"Circulation"},{"key":"B56","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1016\/j.athoracsur.2016.02.107","article-title":"Comparison of radial artery and saphenous vein graft stenosis more than 5 years after coronary artery bypass grafting","volume":"102","author":"Yamasaki","year":"2016","journal-title":"Ann Thorac Surg"},{"key":"B57","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1097\/00000441-200111000-00002","article-title":"History of medical ethics and perspectives on disparities in minority recruitment and involvement in health research","volume":"322","author":"Seto","year":"2001","journal-title":"Am J Med Sci"},{"key":"B58","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.athoracsur.2020.08.075","article-title":"Sex, racial, and ethnic disparities in U.S. Cardiovascular trials in more than 230,000 patients","volume":"112","author":"Preventza","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"B59","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ahj.2013.03.022","article-title":"Reporting and representation of ethnic minorities in cardiovascular trials: a systematic review","volume":"166","author":"Zhang","year":"2013","journal-title":"Am Heart J"},{"key":"B60","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1093\/eurheartj\/ehu279","article-title":"Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A \u2018state-of-the-art\u2019 paper","volume":"35","author":"Patti","year":"2014","journal-title":"Eur Heart J"},{"key":"B61","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1160\/TH10-04-0232","article-title":"Impact of race and gender on antithrombotic therapy","volume":"104","author":"Capodanno","year":"2010","journal-title":"Thromb Haemost"},{"key":"B62","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.annepidem.2005.06.052","article-title":"Platelet counts differ by sex, ethnicity, and age in the United States","volume":"16","author":"Segal","year":"2006","journal-title":"Ann Epidemiol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1067\/mhl.2001.118764","article-title":"Sex differences and the effects of sex hormones on hemostasis and vascular reactivity","volume":"30","author":"Schwertz","year":"2001","journal-title":"Heart Lung"},{"key":"B64","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/MBC.0b013e3282ff76ae","article-title":"Race and sex differences in thrombogenicity: risk of ischemic events following coronary stenting","volume":"19","author":"Gurbel","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1093\/ehjcvp\/pvw042","article-title":"Gender differences in the effects of cardiovascular drugs","volume":"3","author":"Tamargo","year":"2017","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"B66","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ijcard.2022.10.166","article-title":"Sex differences among patients receiving ticagrelor monotherapy or aspirin after coronary bypass surgery: a prespecified subgroup analysis of the TiCAB trial","volume":"370","author":"Sandner","year":"2023","journal-title":"Int J Cardiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1093\/icvts\/ivab191","article-title":"Sex differences in outcomes following coronary artery bypass grafting: a meta-analysis","volume":"33","author":"Bryce Robinson","year":"2021","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"B68","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/eurheartj\/ehab504","article-title":"Sex differences in outcomes after coronary artery bypass grafting: a pooled analysis of individual patient data","volume":"43","author":"Gaudino","year":"2021","journal-title":"Eur Heart J"},{"key":"B69","doi-asserted-by":"publisher","first-page":"103","DOI":"10.11909\/j.issn.1671-5411.2019.02.006","article-title":"Antiplatelet therapy in very elderly and comorbid patients with acute coronary syndromes","volume":"16","author":"De Rosa","year":"2019","journal-title":"J Geriatr Cardiol"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1161\/CIRCULATIONAHA.118.032078","article-title":"P2y 12 -ADP receptor blockade in chronic kidney disease patients with acute coronary syndromes: review of the current evidence","volume":"138","author":"Bonello","year":"2018","journal-title":"Circulation"},{"key":"B71","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.athoracsur.2021.03.061","article-title":"Ticagrelor or aspirin after coronary artery bypass in patients with chronic kidney disease","volume":"113","author":"Sandner","year":"2022","journal-title":"Ann Thorac Surg"}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1125126\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,8]],"date-time":"2023-03-08T01:36:07Z","timestamp":1678239367000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2023.1125126\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,8]]},"references-count":71,"alternative-id":["10.3389\/fcvm.2023.1125126"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2023.1125126","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,8]]},"article-number":"1125126"}}